New hires and promotions in the biopharma industry, including: Brainstorm, Harpoon, Locana, Plus, Rockwell, Sutura.
Biopharmas raising money in public or private financings, including: Aclaris, Aspen Neuroscience, Bellerophon, Keros, Phio, Therapix, Vivus.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Eusa, Horizon, Inflarx, Inmed, Lidds, Novo Nordisk, Oncoceutics, Orchard, Ose, Theranexus.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amgen, Astellas, Azurrx, Cardiol, Citius, China Shijiazhuang Pharmaceutical, Daiichi Sankyo, Danaher, Daré, Diffusion, Editas, Eisai, Emergent Biosolutions, Eyepoint, Flexion, GE, Immunitybio, Innovation Pharmaceuticals, Macromoltek, Modalis, Novavax, Novellus, Ocumension, Oramed, Ostrich, Paratek, Regenxbio, Sanbio, Seikagaku, Soleo Health, Sorrento, Ultragenyx, Vaccibody.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acasti, Aveo, Concert, Cytodyn, Diurnal, Faron, Mallinckrodt, Mesoblast, Novoteris, Orchard, Y-mabs.
The latest global regulatory news, changes and updates affecting biopharma.